EZH2
415M-14
Cell Marque Bajo pedido

EZH2

Enhancer of zeste homolog 2 (EZH2) is the catalytic subunit of polycomb repressive complex 2 (PRC2).1 It generates a methylation epigenetic mark at lysine 27 residue of histone H3 (H3K27me3) in order to silence gene expression.1 EZH2 target genes are involved in a variety of biological processes such as stem cell pluripotency, cell proliferation, and oncogenic transformation. 1,2 Anti-EZH2 expression has been found in a variety of malignancies including prostate, breast, uterine, gastric, and renal cell cancers in addition to melanoma. 1-4 Anti-EZH2 expression has been reported in non-small cell lung cancers and lymphoma.1 The EZH2 protein is usually not detected in normal breast ductal epithelium. EZH2 is usually expressed in follicular centers, but not in mantle zones, follicular and interfollicular T cells, plasma cells or NK/T cells. However, its expression can be seen in most B-cell

Anatomic/Surgical Monoclonal Mouse

Datos técnicos

Reactividad
paraffin
Visualización
nuclear
Control
prostate adenocarcinoma, tonsil, breast carcinoma
Estabilidad
up to 36 mos. at 2-8°C